Медицинская литература. Новинки

 

 

 

 

 

 

РАК ОКОЛОЩИТОВИДНЫХ ЖЕЛЕЗ

Вы можете загрузить полный текст статьи в формате pdf

Ключевые слова:

Литература:
1. Shane E., Bilezikian J. Parathyroid carcinoma: a review of 62
patients // Endocr. Rev. 1982 . N3. P. 218–226.
2. Shane E., Bilezikian J. Parathyroid carcinoma. In: Williams C.J.,
Green M.R., Raghaven D., eds. Textbook of uncommon cancer.
New York, Wiley & Sons, 1987. P. 763–771.
3. Cohn K., Silverman M., Corrado J., Sedgewick C. Parathyroid car
cinoma: The Lahey Clinic experience // Surgery. 1985 V. 98.
P. 1095–1110.
4. Hakaim A.G., Esselstyn C.B., Jr. Parathyroid carcinoma: 50year
experience at The Cleveland Clinic Foundation. Cleve Clin. J.
Med. V. 60. 1993 Р. 331–335.
5. Sandelin K., Thompson N.W., Bondeson L. Metastatic parathyroid
carcinoma: dilemmas in management // Surgery. 1991 V. 110.
P. 978–986.
6. Holmes E., Morton D., Ketcham A. Parathyroid carcinoma: a collective review // Ann. Surg. 1969. V. 169. P. 631–640.
7. Schantz A., Castleman B. Parathyroid carcinoma: a study of 70
cases // Cancer. 1973. V. 31. P. 600–605.
8. Wang C., Gaz R. Natural history of parathyroid carcinoma: diagno
sis, treatment, and results // Am. J. Surg. 1985. V. 149. P. 522–527
9. Wynne A., Heerden Jv, Carney J., Fitzpatrick L. Parathyroid carcinoma: clinical and pathological features in 43 patients. Medicine.
1992. V. 71. P. 197–205.
10. Cryns V.L., Rubio M.P., Thor A.D. et al. p53 abnormalities in
human parathyroid carcinoma // J. Clin. Endocrinol. Metab.
1994. V. 78. P. 1320–1324.
11. Shane E. Clinical review 122: Parathyroid carcinoma // J. Clin.
Endocrinol. Metab. 2001. V. 86. P. 485–493.
12. Obara T., Okamoto T., Ito Y. et al. Surgical and medical manage
ment of patients with pulmonary metastasis from parathyroid carcinoma // Surgery. 1993. V. 114. P. 1040–1048.
13. Fujimoto Y., Obara T. How to recognize and treat parathyroid carcinoma // Surg. Clin. North Am. 1987. V. 67. P. 343–357.
14. Obara T., Fujimoto Y. 1991 Diagnosis and treatment of patients
with parathyroid carcinoma: an update and review // Wld. J. Surg.
V. 15. P. 738–744.
15. Obara T., Okamoto T., Kanbe M., Iihara M. Functioning parathyroid carcinoma: clinicopathologic features and rational treatment
// Semin. Surg. Oncol. 1997. V. 13. P. 134–141.
16. Favia G., Lumachi F., Polistina F., D'Amico D.F. Parathyroid carcinoma: sixteen new cases and suggestions for correct management
// Wld. J. Surg. 1998. V. 22. P. 1225–1230.
17. Lee P.K., Jarosek S.L., Virnig B.A. et al. Trends in the incidence
and treatment of parathyroid cancer in the United States. Cancer.
2007. V. 109. P. 1736–1741.
18. Busaidy N.L., Jimenez C., Habra M.A. et al. Parathyroid carcinoma: A 22year experience. Head Neck. 2004. V. 26. P. 716–726.
19. Kleinpeter K.P., Lovato J.F., Clark P.B. et al. Is parathyroid carcinoma
indeed a lethal disease? // Ann. Surg. Oncol. 2005. N12. P. 260–266.
20. Hamill J., Maoate K., Beasley S.W. et al. Familial parathyroid car
cinoma in a child // J. Paediatr. Child. Health. 2002. V. 38.
P. 314–317.
21. Righi A., Dimosthenous K., Mize J. Mediastinal parathyroid carcinoma with tumor implants in a child: A unique occurrence // Int.
J. Surg. Pathol. 2008. V. 16. P. 458–460.
22. Mashburn M.A., Chonkich G.D., Chase D.R., Petti Jr. G.H.
Parathyroid carcinoma: two new casesdiagnosis, therapy, and
treatment // Laryngoscope. 1987. V. 97. P. 215–218.
23. Christmas T.J., Chapple C.R., Noble J.G. et al.
Hyperparathyroidism after neck irradiation // Br. J. Surg. 1988.
V. 75. P. 873–874.
24. Ireland J., Fleming S., Levison D. et al. Parathyroid carcinoma
associated with chronic renal failure and previous radiotherapy to
the neck // J. Clin. Pathol. 1985. V. 38. P. 1114–1118.
25. Berland Y., Olmer M., Lebreuil G., Grisoli J. Parathyroid carcinoma, adenoma and hyperplasia in a case of chronic renal insufficiency on dialysis. // Clin. Nephrol. 1982. V. 18. P. 154–158.
26. Haghighi P., Astarita R., Wepsic T., Wolf P. Concurrent primary
parathyroid hyperplasia and parathyroid carcinoma // Arch.
Pathol. Lab. Med. 1983. V. 107. P. 349–350.
27. Desch C., Arsensis G., May A., Amatruda J. Parathyroid hyperplasia
and carcinoma within one gland // Am. J. Med. 1984. V. 77.
P. 131–134.
28. Murayama T., Kawabe K., Tagami M. A case of parathyroid carcinoma concurred with hyperperplasia: an electron microscopic
study // J. Urol. 1977. V. 118. P. 126–127.
29. Guazzi A., Gabrielli M., Guadagni G. Cytologic features of a functioning parathyroid carcinoma: a case report // Acta Cytol. 1982.
V. 26. P. 709–713.
30. Parham G., Orr J. Hyperparathyroidism secondary to parathyroid
carcinoma in pregnancy: a case report // J. Reprod. Med. 1987.
V. 32. P. 123–125.
31. Aldinger K.A., Hickey R.C., Ibanez M.L., Samaan N.A. Parathyroid
carcinoma: a clinical study of seven cases of functioning and two
cases of nonfunctioning parathyroid cancer // Cancer. 1982. V. 49.
P. 388–397.
32. Kramer W. Association of parathyroid hyperplasia with neoplasia // Am. J. Clin. Pathol. 1970. V. 53. P. 275–283.
33. Boyle N.H., Ogg C.S., Hartley R.B., Owen W.J. Parathyroid carcinoma secondary to prolonged hyperplasia in chronic renal failure
and in coeliac disease // Eur. J. Surg. Oncol. 1999. V. 25.
P. 100–103.
34. Miki H., Sumitomo M., Inoue H. et al. Parathyroid carcinoma in
patients with chronic renal failure on maintenance hemodialysis //
Surgery. 1996. V. 120. P. 897–901.
35. Tominaga Y., Numano M., Uchida K. et al. Lung metastasis from
parathyroid carcinoma causing recurrent renal hyperparathy
roidism in a hemodialysis patient: Report of a case // Surg. Today.
1995. V. 25. P. 984–986.
36. Frayha R.A., Nassar V.H., Dagher F., Salti I.S. Familial parathy
roid carcinoma // Leban. Med. J. 1972. V. 25. P. 299–309.
37. Dinnen J., Greenwood R., Jone J. et al. Parathyroid carcinoma in
familial hyperparathyroidism // J. Clin. Pathol. 1977. V. 30.
P. 966–975.
38. Mallette L., Bilezikian J., Ketcham A., Aurbach G. Parathyroid car
cinoma in familiar hyperparathyroidism // Am. J. Med. 1974.
V. 57. P. 642–648.
39. Leborgne J., LeNeel J., Brizelin F., Malvy P. Cancer familiar des
parathyroids // J. Chir. 1975. V. 109. P. 315–326.
40. Streeten E.A., Weinstein L.S., Norton J.A. et al. Studies in a kindred
with parathyroid carcinoma // J. Clin. Endocrinol. Metab. 1992.
V. 75. P. 362–366.
41. Kakinuma A., Morimoto I., Nakano Y. et al. Familial primary
hyperparathyroidism complicated with Wilms' tumor. Intern Med.
1994. V. 33. P. 123–126.
42. Wassif W.S., Moniz C.F., Friedman E. et al. Familial isolated
hyperparathyroidism: a distinct genetic entity with an increased
risk of parathyroid cancer // J. Clin. Endocrinol. Metab. 1993.
V. 77. P. 1485–1489.
43. Szabo J., Heath B., Hill V.M. et al. Hereditary hyperparathyroidismjaw
tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21q31 // Am. J. Hum. Genet. 1995 . V. 56. P. 944–950.
44. Cryns V.L., Thor A., Xu H.J. et al. Loss of the retinoblastoma
tumorsuppressor gene in parathyroid carcinoma // N. Engl. J.
Med. 1994. V. 330. P. 757–761.
45. Dotzenrath C., Teh B.T., Farnebo F. et al. Allelic loss of the
retinoblastoma tumor suppressor gene: A marker for aggressive
parathyroid tumors? // J. Clin. Endocrinol. Metab. 1996. V. 81.
P. 3194–3196.
46. Pearce S.H., Trump D., Wooding C. et al. Loss of heterozygosity
studies at the retinoblastoma and breast cancer susceptibility
(BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid
tumours // Clin. Endocrinol. (Oxf). 1996. V. 45. P. 195–200.
47. Subramaniam P., Wilkinson S., Shepherd J.J. Inactivation of
retinoblastoma gene in malignant parathyroid growths: A candidate genetic trigger? Aust. N. Z. J. Surg. 1995. V. 65. P. 714–716.
48. Farnebo F., Auer G., Farnebo L.O. et al. Evaluation of retinoblas
toma and Ki67 immunostaining as diagnostic markers of benign
and malignant parathyroid disease // Wld. J. Surg. 1999. V. 23.
P. 68–74.
49. Shattuck T.M., Kim T.S., Costa J. et al. Mutational analyses of RB
and BRCA2 as candidate tumour suppressor genes in parathyroid
carcinoma // Clin. Endocrinol. (Oxf). 2003. V. 59. P. 180–189.
50. Haven C.J., van Puijenbroek M., Tan M.H. et al. Identification of
MEN1 and HRPT2 somatic mutations in paraffinembedded
(sporadic) parathyroid carcinomas // Clin. Endocrinol. (Oxf).
2007. V. 67. P. 370–376.
51. Vasef M.A., Brynes R.K., Sturm M. et al. Expression of cyclin D1 in
parathyroid carcinomas, adenomas, and hyperplasias: A paraffin
immunohistochemical study // Mod. Pathol. 1999. N12.
P. 412–416.
52. Woodard G.E., Lin L., Zhang J.H. et al. Parafibromin, product of
the hyperparathyroidismjaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression. Oncogene. 2005. V. 24.
P. 1272–1276.
53. Howell V.M., Haven C.J., Kahnoski K. et al. HRPT2 mutations are
associated with malignancy in sporadic parathyroid tumours // J.
Med. Genet. 2003. V. 40. P. 657–663.
54. Carpten J.D., Robbins C.M., Villablanca A. et al. HRPT2, encoding
parafibromin, is mutated in hyperparathyroidismjaw tumor syndrome. Nat. Genet. 2002. V. 32. P. 676–680.
55. Shattuck T.M., Välimäki S., Obara T. et al. Somatic and germline
mutations of the HRPT2 gene in sporadic parathyroid carcinoma // N. Engl. J. Med. 2003. V. 349. P. 1722–1729.
56. Nakajima K. , Umino K., Azuma Y. et al. Stimulating parathyroid
cell proliferation and PTH release with phosphate in organ cultures
obtained from patients with primary and secondary hyperparathyroidism for a prolonged period // J. Bone Miner Metab. 2009.
V. 27. P. 224–233.
57. VelˆazquezFernˆandez D., Laurell C., SaquiSalces M. et al.
Differential RNA expression profile by cDNA microarray in sporadic primary hyperparathyroidism (pHPT): Primary parathyroid
hyperplasia versus adenoma // Wld. J. Surg. 2006. V. 30.
P. 705–713.
58. Forsberg L., Bjorck E., Hashemi J. et al. Distinction in gene expression
profiles demonstrated in parathyroid adenomas by highdensity
oligoarray technology // Eur. J. Endocrinol. 2005. V. 152. P. 459–470.
59. Haven C.J., Howell V.M., Eilers P.H. et al. Gene expression of
parathyroid tumors: Molecular subclassification and identification
of the potential malignant phenotype // Cancer. Res. 2004. V. 64.
P. 7405–7411.
60. Abdelgadir Adam M., Untch B.R., Olson J.A. Jr. Parathyroid carcinoma: current understanding and new insights into gene expression and intraoperative parathyroid hormone kinetics //
Oncologist. 2010. V. 15(1). P. 61–72.
61. Kelly M.D., Sheridan B.F., Farnsworth A.E. et al. Parathyroid carcinoma in a mediastinal sixth parathyroid gland // Aust N. Z. J.
Surg. 1994. V. 64. P. 446–449.
62. Kameyama K., Takami H. Double parathyroid carcinoma //
Endocr. J. 2003. V. 50. P. 477–479.
63. Wang C.A., Gaz R.D. Natural history of parathyroid carcinoma.
Diagnosis, treatment, and results // Am. J. Surg. 1985. V. 149.
P. 522–527.
64. Sandelin K., Tullgren O., Farnebo L.O. Clinical course of metastatic parathyroid cancer // Wld. J. Surg. 1994. V. 18. P. 594–598.
65. Sandelin K., Thompson N.W., Bondeson L. Metastatic parathyroid
carcinoma: Dilemmas in management // Surgery. 1991. V. 110.
P. 978–986.
66. Cordeiro A.C., Montenegro F.L., Kulcsar M.A. et al. Parathyroid
carcinoma // Am. J. Surg. 1998. V. 175. P. 52–55.
67. Hundahl S.A., Fleming I.D., Fremgen A.M., Menck H.R. Two hundred eightysix cases of parathyroid carcinoma treated in the U.S.
between 1985–1995: a National Cancer Data Base Report. The
American College of Surgeons Commission on Cancer and the
American Cancer Society. Cancer. 1999. V. 86. P. 538–544.
68. Levin K., Galante M., Clark O. Parathyroid carcinoma versus
parathyroid adenoma in patients with profound hypercalcemia //
Surgery. 1999. V. 101. P. 647–660.
69. Silverberg S.J., Shane E., de la Cruz L. et al. Skeletal disease in pri
mary hyperparathyroidism // J. Bone. Miner. Res. 1989. N4.
P. 283–291.
70. Silverberg S., Shane E., Jacobs T. et al. Nephrolithiasis and bone
involvement in primary hyperparathyroidism // Am. J. Med. 1990.
V. 89. Р. 327–334.
71. Hara H., Igarashi A., Yano Y. et al. Ultrasonographic features of
parathyroid carcinoma // Endocr. J. 2001. V. 48. P. 213–217.
72. Singhal T., Jacobs M., Mantil J.C. Tc99m pertechnetate/sestamibi
subtraction scan in a case of parathyroid carcinoma // Clin. Nucl.
Med. 2008. V. 33. P. 196–197.
73. Aigner R.M., Fueger G.F., Lax S. A case of parathyroid carcinoma
visualized on Tc99msestamibi scintigraphy. Nuklearmedizin.
1997. V. 36. P. 256–258.
74. AlSobhi S., Ashari L.H, Ingemansson S. Detection of metastatic
parathyroid carcinoma with Tc99m sestamibi imaging // Clin.
Nucl. Med. 1999. V. 24. P. 21–23.
75. Clark P., Wooldridge T., Kleinpeter K. et al. Providing optimal preoperative localization for recurrent parathyroid carcinoma: A combined parathyroid scintigraphy and computed tomography
approach // Clin. Nucl. Med. 2004. V. 29. P. 681–684.
76. Agarwal G., Dhingra S., Mishra S.K. et al. Implantation of parathyroid carcinoma along fine needle aspiration track. Langenbecks
Arch. Surg. 2006. V. 391. P. 623–626.
77. Spinelli C., Bonadio A.G., Berti P. et al. Cutaneous spreading of
parathyroid carcinoma after fine needle aspiration cytology.
J. Endocrinol. Invest. 2000. V. 23. P. 255–257.
78. Koea J.B., Shaw J.H. Parathyroid cancer: Biology and management. Surg. Oncol. 1999. N8. P. 155–165.
79. Shortell C.K., Andrus C.H., Phillips C.E. Jr. et al. Carcinoma of the parathy
roid gland: A 30year experience. Surgery. 1991. V. 110. P. 704–708.
80. Clayman G.L., Gonzalez H.E., ElNaggar A. et al. Parathyroid carcinoma: Evaluation and interdisciplinary management // Cancer.
2004. V. 100. P. 900–905.
81. Vetto J.T., Brennan M.F., Woodruf J. et al. Parathyroid carcinoma:
Diagnosis and clinical history // Surgery. 1993. V. 114. P. 882–892.
82. Sandelin K., Auer G., Bondeson L. et al. Prognostic factors in
parathyroid cancer: A review of 95 cases // Wld. J. Surg. 1992.
V. 16. P. 724–731.
83. Irvin GL 3rd, Solorzano C.C., Carneiro D.M. Quick intraoperative
parathyroid hormone assay: Surgical adjunct to allow limited
parathyroidectomy, improve success rate, and predict outcome //
Wld. J. Surg. 2004. V. 28. P. 1287–1292.
84. Clary B.M., Garner S.C., Leight G.S. Jr. Intraoperative parathyroid
hormone monitoring during parathyroidectomy for secondary
hyperparathyroidism. Surgery. 1997;122:1034–1038; discussion
1038–1039.
85. Solorzano C.C., CarneiroPla D.M. Lew J.I. et al. Intraoperative
parathyroid hormone monitoring in patients with parathyroid cancer // Ann. Surg. Oncol. 2007. V. 14. P. 3216–3222.
86. Howell V.M., Gill A., Clarkson A. et al. Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma // J. Clin.
Endocrinol. Metab. 2009. V. 94. P. 434–441.
87. Gill A.J., Clarkson A., Gimm O. et al. Loss of nuclear expression of
parafibromin distinguishes parathyroid carcinomas and hyper
parathyroidismjaw tumor (HPTJT) syndromerelated adenomas
from sporadic parathyroid adenomas and hyperplasias // Am. J.
Surg. Pathol. 2006. V. 30. P. 1140–1149.
88. Silverberg S.J., Rubin M.R., Faiman C. et al. Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable
parathyroid carcinoma // J. Clin. Endocrinol. Metab. 2007. V. 92.
P. 3803–3808.
89. Collins M.T., Skarulis M.C., Bilezikian J.P. et al. Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimimetic agent // J. Clin. Endocrinol. Metab. 1998. V. 83. P. 1083–1088.
90. Yip L., Seethala R.R., Nikiforova M.N. et al. Loss of heterozygosity of selected tumor suppressor genes in parathyroid carcinoma //
Surgery. 2008. V. 144. P. 949–955.

Parathyroid carcinoma

Keywords: